Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,151,197 papers from all fields of science
Search
Sign In
Create Free Account
Dek protein, human
Known as:
Protein DEK
, DEK Protein
, oncoprotein DEK, human
Expand
Protein DEK (375 aa, ~43 kDa) is encoded by the human DEK gene. This protein plays a role in transcriptional regulation via chromatin modification.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
16 relations
Cell Nucleus
Chromatin
Chromatin Remodeling Factor
DEK gene
Expand
Broader (2)
Chromosomal Proteins, Non-Histone
Oncogene Proteins
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Significance of DEK overexpression for the prognostic evaluation of non-small cell lung carcinoma.
Xin Liu
,
Dongdong Qi
,
+5 authors
Wenbin Gao
Oncology Report
2016
Corpus ID: 5265830
In the present study, we explored the role of DEK expression for the prognostic evaluation of non-small cell lung carcinoma…
Expand
2012
2012
DEK regulates hematopoietic stem engraftment and progenitor cell proliferation.
H. Broxmeyer
,
F. Kappes
,
+5 authors
D. Markovitz
Stem Cells and Development
2012
Corpus ID: 27799318
DEK is a biochemically distinct protein that is generally found in the nucleus, where it is vital to global heterochromatin…
Expand
2011
2011
Oncoprotein DEK as a tissue and urinary biomarker for bladder cancer
A. Datta
,
M. Adelson
,
Y. Mogilevkin
,
E. Mordechai
,
A. Sidi
,
J. Trama
BMC Cancer
2011
Corpus ID: 9761324
BackgroundBladder cancer is a significant healthcare problem in the United States of America with a high recurrence rate. Early…
Expand
2010
2010
The Oncogene DEK Promotes Leukemic Cell Survival and Is Downregulated by both Nutlin-3 and Chlorambucil in B-Chronic Lymphocytic Leukemic Cells
P. Secchiero
,
R. Voltan
,
M. G. di Iasio
,
E. Melloni
,
M. Tiribelli
,
G. Zauli
Clinical Cancer Research
2010
Corpus ID: 17495528
Purpose: To characterize the role of the oncogene DEK in modulating the response to either Nutlin-3, a small-molecule inhibitor…
Expand
2006
2006
Hypophosphorylation of the architectural chromatin protein DEK in death‐receptor‐induced apoptosis revealed by the isotope coded protein label proteomic platform
A. Tabbert
,
F. Kappes
,
R. Knippers
,
J. Kellermann
,
F. Lottspeich
,
E. Ferrando-May
Proteomics
2006
Corpus ID: 17615932
During apoptosis nuclear morphology changes dramatically due to alterations of chromatin architecture and cleavage of structural…
Expand
2005
2005
Expression and significance of tumor-related genes in HCC.
Zi-li Lü
,
D. Luo
,
J. Wen
World Journal of Gastroenterology
2005
Corpus ID: 22039746
AIM To investigate the expression and clinical significance of DEK, cyclin D1, insulin-like growth factor II (IGF-II), glypican 3…
Expand
2005
2005
Distribution of the chromatin protein DEK distinguishes active and inactive CD21/CR2 gene in pre- and mature B lymphocytes.
Hong-gang Hu
,
H. Illges
,
C. Gruss
,
R. Knippers
International Immunology
2005
Corpus ID: 43734798
DEK is an abundant and ubiquitous chromatin protein that has only recently attracted attention. DEK preferentially binds to…
Expand
2000
2000
Autoantibodies to DEK oncoprotein in systemic lupus erythematosus (SLE)
I. Wichmann
,
N. Respaldiza
,
J. García-Lozano
,
M. Montes
,
J. Sánchez-Román
,
A. Nunez‐roldan
Clinical and Experimental Immunology
2000
Corpus ID: 6087607
Autoantibodies against the transcriptional DEK protein have been considered characteristic of the pauciarticular onset subtype of…
Expand
1998
1998
Autoantibodies to DEK oncoprotein in a patient with systemic lupus erythematosus and sarcoidosis.
X. Dong
,
M. Michelis
,
J. Wang
,
R. Bose
,
T. deLange
,
W. Reeves
Arthritis & Rheumatism
1998
Corpus ID: 34454733
A patient was identified with an unusual autoimmune syndrome consisting of systemic lupus erythematosus and sarcoidosis. Her…
Expand
1991
1991
Dihydroergocryptine in the treatment of Parkinson's disease: a six months' double-blind clinical trial.
E. Martignoni
,
Claudio Pacchetti
,
L. Sibilla
,
P. Bruggi
,
Marco Pedevilla
,
Giuseppe Nappi
Clinical neuropharmacology
1991
Corpus ID: 39094241
The short-term efficacy of dihydro-alpha-ergocryptine (DEK), a hydrogenate ergot derivative with dopamine (DA) agonist properties…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE